Mounjaro (tirzepatide) is a groundbreaking injectable medication recently approved for managing type 2 diabetes. It combines the action of two incretin hormones—GLP-1 and GIP receptor agonists—to help regulate blood sugar levels more effectively than traditional treatments. This dual-action approach improves insulin secretion, reduces glucagon levels, and slows gastric emptying,...